2nd Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

***no specific bill, Raising awareness of Hepatitis C H.R. 2552, to establish, promote and support a comprehensive prevention, research, and medical management referral program for hepatitis C infection

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst.
MICHELLE P EASTON New Chief Health Counsel, Sen. Cmte. on Finance;
ISAAC A FORDJOUR —
LINDA E TARPLIN Congressman Billy Tauzin
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg.

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 2552 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.